Home / Aprepitant / Sweden
SE ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in Sweden
Is there an Aprepitant shortage in Sweden?
Yes. As of 2 Nov 2026, 2 Aprepitant products are reported short in Sweden, the first since 24 Aug 2026. The company estimate for the return is 30 Dec 2026 (latest 31 Mar 2027). Main reason: not stated.
Also short in United States, Canada, Germany, France, Italy, Spain, Ireland, Austria, Czechia, Norway, Australia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Aprepitant STADA 125 mg + 80 mg Blister, 1 kapsel 125 mg + 2 kapslar 80 mg | STADA Arzneimittel AG | 24 Aug 2026 | 31 Mar 2027 | Not stated |
| SE | Aprepitant STADA 80 mg Blister, 5 x 1 kapsel (endos) | STADA Arzneimittel AG | 13 Oct 2026 | 30 Dec 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.